HNN3.0
Register
Register
Register

Project cooperationUpdated on 19 March 2026

Translational IVD diagnostics from nutritional immunity and metal-ion economy

Groupleader at Institute of Microbiology AS CR

Prague 4, Czech Republic

About

Our group offers translational expertise for next-generation, patient-centred infection diagnostics and IVD development. We work at the interface of nutritional immunity and host–pathogen metal-ion economy, developing non-invasive biomarker panels that combine host-response proteins, elemental signatures, and microbial siderophore/metallophore readouts. We contribute assay concept generation, biomarker selection, analytical workflows based on LC-MS, ICP-MS, and immunoassays, as well as clinically relevant sample strategies for bacterial, fungal, and polymicrobial infections. We are particularly interested in projects aiming to convert novel biomarkers into robust diagnostic solutions supported by evidence on analytical performance, clinical relevance, and regulatory readiness.

Topic

  • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies

Type

  • Partner seeks Consortium/Coordinator

Organisation

Institute of Microbiology AS CR

R&D Institution

Prague, Czech Republic

Similar opportunities

  • Project cooperation

    CircRNA Biomarkers for Post-Infection Neurological Conditions

    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions

    Lalit Kaurani

    Group Leader at Institute of Physiology of the Czech Academy of Sciences

    Prague, Czech Republic

  • Project cooperation

    Clinical microbiology and advanced diagnostics for infectious diseases and antimicrobial resistance in Horizon Europe projects

    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Silvia Angeletti

    Full Professor Clinical Pathology and Head of Laboratory Unit at Fondazione Policlinico Universitario Campus Bio-Medico

    Rome, Italy

  • Project cooperation

    Integrated Omics–Driven Diagnostic Innovation Laboratory

    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Vel Murugan

    Professor at AZ Board of Regents on behalf of Arizona State University

    Tempe, United States